American Vanguard subsidiary invests in Bi-PA

By investing in Biological Products for Agriculture (Bi-PA), American Vanguard will gain distribution rights for Bi-PA’s Vintec Trichoderma biological fungus control agent.

AMVAC-Netherlands BV, a subsidiary of American Vanguard Corporation, recently invested in Biological Products for Agriculture (Bi-PA), giving American Vanguard a 15 percent share in Bi-PA's total valuation.

“We are very pleased to secure an ownership position in this outstanding biological development firm with its open innovation platform and novel business model.” Eric Wintemute, chairman and CEO of American Vanguard said. “Our industry has come to recognize that biological solutions technology is an important complement to synthetic chemistry and genetically modified defenses in crop protection and noncrop applications." 

As part of the deal, American Vanguard also will receive distribution rights in the Americas for Bi-PA’s Vintec Trichoderma biological fungus control agent and subsequent products, and new products and technologies that emerge from Bi-PA’s scientific research programs and future collaborations. 

“The investment by AMVAC in Bi-PA fits perfectly in the strategy of Bi-PA, focusing on development and registration of novel biological solutions for the crop protection industry and relying on strong marketing partners for the distribution of our products,” Johan De Saegher, CEO of Bi-PA said, “Through AMVAC, Bi-PA gets access to a strong market channel for the Americas and to a network of expertise in this region.”

Organizations in this story

American Vanguard Corporation 4695 Macarthur Ct Newport Beach, CA - 92660

Get notified the next time we write about American Vanguard Corporation!